Liminal Biosciences Inc

NASDAQ:LMNL   11:29:41 AM EDT
0.45
+0.01 (+2.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Liminal Biosciences Inc Stock, NASDAQ:LMNL

440, boulevard Armand-Frappier, Suite 300, Laval, Qu?©bec H7V 4B4
Canada
Phone: +1.450.781.0115
Number of Employees: 48

Description

Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach. The firm has business operations in Canada and the United Kingdom. Its small molecule product candidate, fezagepras, has completed a Phase 1 multi-ascending dose clinical trial and anticipate conducting a comparative Phase 1a single ascending dose clinical trial to provide comparative data to support development plan. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.